相关实验视频
Updated: Jul 20, 2025
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.4K
伊朗希拉兹的炎症性肠病的经济负担,伊朗
Leila Rahmati1, Alireza Mooghali2, Seyed Mohammad Hosein Kamani2
1Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, Department of Management, Payame Noor University, Tehran, Iran.
Archives of Iranian medicine
|August 6, 2023
概括
炎症性肠病 (IBD) 由于医疗保健的使用和生产力的损失,患者每年需要1229.74美元. 早期诊断和治疗可以帮助减少这些对个人和社会的重大经济负担.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 胃肠病学 胃肠病学
背景情况:
- 慢性疾病,包括炎症性肠病 (IBD),构成了日益严重的全球健康挑战,特别是在发展中国家.
- 在全球范围内,IBD对个人和医疗保健系统造成了巨大的财务压力.
- 了解IBD的经济影响对于资源分配和政策制定至关重要.
研究的目的:
- 为了估计炎症性肠病 (IBD) 的经济负担,在伊朗的雪拉兹.
- 量化患者与IBD相关的直接和间接成本.
- 为决策者提供有关IBD财务影响的数据.
主要方法:
- 一个描述性的,横截面研究,使用基于人力资本理论的疾病成本方法.
- 直接和间接成本是使用流行方法和自下而上的方法计算的.
- 通过患者记录,会计系统,采访和关于社会经济地位,医疗费用和缺勤率的验证问卷收集的数据.
主要成果:
- 每名IBD患者的年度经济总成本估计为1229.74美元.
- 增加医疗保健利用率和生产力损失被确定为疾病成本的关键驱动因素.
- 该研究强调了对患者和社会的重大财务影响.
结论:
- 炎症性肠病 (IBD) 对患者,家庭和社会来说是一个相当大的经济负担.
- 早期诊断,IBD恶化的有效管理和适当的治疗可以减轻治疗成本和生产力损失.
- 政策制定者应该优先考虑IBD预防和治疗服务,并与现有卫生资源保持一致.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
01:30Inflammatory Bowel Disease II: Crohn's Disease
291
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
291
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
215
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
215
01:29Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
01:17Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
01:21Inflammatory Bowel Disease V: Surgical Management
170
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
170